| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 14:41:05 UTC |
|---|
| Update Date | 2021-09-26 23:09:40 UTC |
|---|
| HMDB ID | HMDB0255114 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N-Desethyl Sunitinib |
|---|
| Description | N-[2-(ethylamino)ethyl]-5-[(5-fluoro-2-hydroxy-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboximidic acid belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. Based on a literature review very few articles have been published on N-[2-(ethylamino)ethyl]-5-[(5-fluoro-2-hydroxy-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-desethyl sunitinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-Desethyl Sunitinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CCNCCN=C(O)C1=C(C)NC(C=C2C(O)=NC3=C2C=C(F)C=C3)=C1C InChI=1S/C20H23FN4O2/c1-4-22-7-8-23-20(27)18-11(2)17(24-12(18)3)10-15-14-9-13(21)5-6-16(14)25-19(15)26/h5-6,9-10,22,24H,4,7-8H2,1-3H3,(H,23,27)(H,25,26) |
|---|
| Synonyms | | Value | Source |
|---|
| N-[2-(Ethylamino)ethyl]-5-[(5-fluoro-2-hydroxy-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboximidate | Generator |
|
|---|
| Chemical Formula | C20H23FN4O2 |
|---|
| Average Molecular Weight | 370.428 |
|---|
| Monoisotopic Molecular Weight | 370.18050416 |
|---|
| IUPAC Name | N-[2-(ethylamino)ethyl]-5-[(5-fluoro-2-hydroxy-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboximidic acid |
|---|
| Traditional Name | N-[2-(ethylamino)ethyl]-5-[(5-fluoro-2-hydroxyindol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboximidic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCNCCN=C(O)C1=C(C)NC(C=C2C(O)=NC3=C2C=C(F)C=C3)=C1C |
|---|
| InChI Identifier | InChI=1S/C20H23FN4O2/c1-4-22-7-8-23-20(27)18-11(2)17(24-12(18)3)10-15-14-9-13(21)5-6-16(14)25-19(15)26/h5-6,9-10,22,24H,4,7-8H2,1-3H3,(H,23,27)(H,25,26) |
|---|
| InChI Key | LIZNIAKSBJKPQC-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Indoles and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Indole or derivatives
- Aryl fluoride
- Aryl halide
- Substituted pyrrole
- Benzenoid
- Pyrrole
- Heteroaromatic compound
- Cyclic carboximidic acid
- Propargyl-type 1,3-dipolar organic compound
- Azacycle
- Organic 1,3-dipolar compound
- Secondary amine
- Carboximidic acid
- Carboximidic acid derivative
- Secondary aliphatic amine
- Organic nitrogen compound
- Organofluoride
- Organohalogen compound
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Amine
- Organic oxygen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.4844 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.49 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1029.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 187.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 134.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 166.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 85.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 336.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 375.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 423.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 749.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 377.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 991.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 227.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 293.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 320.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 265.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 35.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-Desethyl Sunitinib,3TMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)[NH]C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 3175.5 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)[NH]C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 2941.5 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)[NH]C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 4133.1 | Standard polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #2 | CCNCCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C | 3136.5 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #2 | CCNCCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C | 2921.2 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #2 | CCNCCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C | 4030.4 | Standard polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #3 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 3263.5 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #3 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 3135.3 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #3 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 4050.4 | Standard polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #4 | CCN(CCN=C(O)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 3257.1 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #4 | CCN(CCN=C(O)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 3060.0 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,3TMS,isomer #4 | CCN(CCN=C(O)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 4225.8 | Standard polar | 33892256 | | N-Desethyl Sunitinib,4TMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 3223.2 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,4TMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 3028.6 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,4TMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C)C1=C(C)N([Si](C)(C)C)C(C=C2C(O[Si](C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C | 3915.9 | Standard polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)[NH]C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 3676.3 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)[NH]C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 3445.5 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)[NH]C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 4204.7 | Standard polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #2 | CCNCCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C | 3603.9 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #2 | CCNCCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C | 3425.7 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #2 | CCNCCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C | 4116.2 | Standard polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #3 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 3798.9 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #3 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 3611.7 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #3 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 4161.1 | Standard polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #4 | CCN(CCN=C(O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 3792.2 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #4 | CCN(CCN=C(O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 3627.5 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,3TBDMS,isomer #4 | CCN(CCN=C(O)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 4297.3 | Standard polar | 33892256 | | N-Desethyl Sunitinib,4TBDMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 3879.7 | Semi standard non polar | 33892256 | | N-Desethyl Sunitinib,4TBDMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 3649.0 | Standard non polar | 33892256 | | N-Desethyl Sunitinib,4TBDMS,isomer #1 | CCN(CCN=C(O[Si](C)(C)C(C)(C)C)C1=C(C)N([Si](C)(C)C(C)(C)C)C(C=C2C(O[Si](C)(C)C(C)(C)C)=NC3=CC=C(F)C=C23)=C1C)[Si](C)(C)C(C)(C)C | 4051.4 | Standard polar | 33892256 |
|
|---|